Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,572.81
+24.641.59%
Number of Gainers:4
Number of Losers:2
Number of Flat:1
PE:- -
High:1,592.41
Open:1,550.74
Low:1,550.74
Close:1,548.17
Volume:46.36M
Turnover:4.78B
Market Cap:1.64T
Float Cap:1.57T

Loading ...

U.S. Research Roundup- Eli Lilly, McDonald's, Welltower

Reuters
·
19 mins ago

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
2 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
5 hours ago

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
11 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
11 hours ago

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
12 hours ago

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
12 hours ago

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
13 hours ago

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
15 hours ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
15 hours ago

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
15 hours ago

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Yesterday

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Yesterday

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Yesterday

Eli Lilly Announces R$ 0.2 Per Unit Dividend for 3Q 2026 BDRs

Reuters
·
Yesterday

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Yesterday

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Yesterday

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Yesterday

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Yesterday

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Yesterday